Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest Revenue

Below are the drug manufacturers-other stocks on the NYSE in terms of revenue. The trailing-twelve-month revenue at Teva Pharmaceutical Industries TEVA is $20.54 billion. Teva's ROE for the same period is 11.36%. The trailing-twelve-month revenue at Novo Nordisk A/S NVO is $14.32 billion. Novo Nordisk's PEG ratio is 2.02. The trailing-twelve-month revenue at Allergan AGN is $6.74 billion. Allergan's EPS for the same period is $4.25. The trailing-twelve-month revenue at Dr. Reddy's Laboratories RDY is $2.25 billion. Dr. Reddy's operating margin for the same period is 19.87%.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Trading IdeasDrug Manufacturers-Other IndustryNYSErevenue
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!